DECEMBER 2017 NEWSFEED

  • U.S. FDA Approves New Diabetes Drug from Merck and Pfizer
    A new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration said, adding another competitor to a growing class of treatments. Read the full story here: Reuters
  • Why Having More Friends Reduces Your Risk of Type 2 Diabetes
    Researchers at the Maastricht University Medical Center in the Netherlands found that people with larger social groups receive fewer type 2 diabetes diagnoses compared to socially isolated people. The study suggests that promoting social interaction could prevent or treat type 2 diabetes. Read the full story here: PBS News Hour
  • FDA Approves Diabetes Drug That Also Helps with Weight Loss
    U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight. Danish drugmaker Novo Nordisk said the Food and Drug Administration approved its once-a-week shot for people with Type 2 diabetes. The drug, Ozempic, also known as semaglutide, works by stimulating the body’s own insulin production and reducing appetite. Read the full article here: CBS NEWS
  • Radical Diet Can Reverse Type 2 Diabetes, New Study Shows
    A radical low-calorie diet can reverse type 2 diabetes, even six years into the disease, a new study has found. A new study from Newcastle and Glasgow Universities shows that the disease can be reversed by losing weight, so that sufferers no longer have to take medication and are free of the symptoms and risks. Nine out of 10 people in the trial who lost 15kg (two-and-a-half stone) or more put their type 2 diabetes into remission. Read full story here: The Guardian
Disclaimer. The content, information, and links on this page are intended for informational and educational purposes only, and does NOT constitute any medical professional advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.